Latest filing published 03 Jun 2025 for OMNICELL, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robin Gene Seim appears in our data through filings on Omnicell, Inc. shares, published by SEC (Form 4). Between 4 January 2016 and 1 June 2025, the trades on record add up to 48 filings.
No open-market purchase appears, only 12 sales worth €5.1M. The rest of the record consists of 27 share grants and 7 option exercises.
The latest filing, published on 3 June 2025, reports a share grant in Omnicell, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations